5P01AG060882-03 |
2022 |
$126184 |
7909 |
Administrative Core |
WISNIEWSKI, THOMAS M |
5P01AG060882-03 |
2022 |
$255384 |
7910 |
Proteomics/Neuropathology Core |
UEBERHEIDE, BEATRIX MAGDALENA |
5P01AG060882-03 |
2022 |
$249877 |
7911 |
Transgenic/Behavior Core |
MAR, ADAM CHRISTOPHER |
5P01AG060882-03 |
2022 |
$252535 |
7912 |
Biostatistics/Bioinformatics Core |
SHAO, YONGZHAO |
5P01AG060882-03 |
2022 |
$430605 |
7913 |
Proteomic studies on the role of Apolipoprotein E and other amyloid associated proteins in AD |
UEBERHEIDE, BEATRIX MAGDALENA |
5P01AG060882-03 |
2022 |
$620426 |
7914 |
Blocking the binding of Aβ and apoE as a novel therapeutic approach for AD |
WISNIEWSKI, THOMAS M |
5P01AG060882-03 |
2022 |
$463850 |
7915 |
Immunomodulation targeting abnormal conformation and the influence of apoE |
GONI, FERNANDO |
5P01AG060882-02 |
2021 |
$126184 |
7909 |
Administrative Core |
WISNIEWSKI, THOMAS M |
5P01AG060882-02 |
2021 |
$268944 |
7910 |
Proteomics/Neuropathology Core |
UEBERHEIDE, BEATRIX MAGDALENA |
5P01AG060882-02 |
2021 |
$249867 |
7911 |
Transgenic/Behavior Core |
MAR, ADAM CHRISTOPHER |
5P01AG060882-02 |
2021 |
$257620 |
7912 |
Biostatistics/Bioinformatics Core |
SHAO, YONGZHAO |
5P01AG060882-02 |
2021 |
$435690 |
7913 |
Proteomic studies on the role of Apolipoprotein E and other amyloid associated proteins in AD |
UEBERHEIDE, BEATRIX MAGDALENA |
5P01AG060882-02 |
2021 |
$634903 |
7914 |
Blocking the binding of Aβ and apoE as a novel therapeutic approach for AD |
WISNIEWSKI, THOMAS M |
5P01AG060882-02 |
2021 |
$474020 |
7915 |
Immunomodulation targeting abnormal conformation and the influence of apoE |
GONI, FERNANDO |
1P01AG060882-01A1 |
2020 |
$124489 |
7909 |
Administrative Core |
WISNIEWSKI, THOMAS M |
1P01AG060882-01A1 |
2020 |
$295944 |
7910 |
Proteomics/Neuropathology Core |
UEBERHEIDE, BEATRIX MAGDALENA |
1P01AG060882-01A1 |
2020 |
$223492 |
7911 |
Transgenic/Behavior Core |
MAR, ADAM CHRISTOPHER |
1P01AG060882-01A1 |
2020 |
$274570 |
7912 |
Biostatistics/Bioinformatics Core |
SHAO, YONGZHAO |
1P01AG060882-01A1 |
2020 |
$453912 |
7913 |
Proteomic studies on the role of Apolipoprotein E and other amyloid associated proteins in AD |
UEBERHEIDE, BEATRIX MAGDALENA |
1P01AG060882-01A1 |
2020 |
$634976 |
7914 |
Blocking the binding of Abeta and apoE as a novel therapeutic approach for AD |
WISNIEWSKI, THOMAS M |
1P01AG060882-01A1 |
2020 |
$477410 |
7915 |
Immunomodulation targeting abnormal conformation and the influence of apoE |
GONI, FERNANDO |